171 related articles for article (PubMed ID: 21225496)
1. CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle.
Sengul D; Sengul I; Astarci MH; Ustun H; Mocan G
Pol J Pathol; 2010; 61(3):140-6. PubMed ID: 21225496
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of basal cell carcinoma and benign tumors of cutaneous appendages originating from hair follicles by using CD34.
Sengul D; Sengul I; Astarci MH; Ustun H; Mocan G
Asian Pac J Cancer Prev; 2010; 11(6):1615-9. PubMed ID: 21338206
[TBL] [Abstract][Full Text] [Related]
3. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
4. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
Sellheyer K; Krahl D
Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
6. p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
Krahl D; Sellheyer K
Br J Dermatol; 2010 Jul; 163(1):138-45. PubMed ID: 20184585
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of immunohistochemistry in distinguishing trichoepithelioma and basal cell carcinoma: evaluation using tissue microarray samples.
Tebcherani AJ; de Andrade HF; Sotto MN
Mod Pathol; 2012 Oct; 25(10):1345-53. PubMed ID: 22684216
[TBL] [Abstract][Full Text] [Related]
8. CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma.
Leblebici C; Bambul Sığırcı B; Kelten Talu C; Koca SB; Huq GE
Int J Surg Pathol; 2019 Feb; 27(1):19-27. PubMed ID: 29938548
[TBL] [Abstract][Full Text] [Related]
9. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
Wagoner J; Keehn C; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
[TBL] [Abstract][Full Text] [Related]
12. Trichoepithelioma of the vulva: report of a case and review of the literature.
Heller J; Roche N; Hameed M
J Low Genit Tract Dis; 2009 Jul; 13(3):186-7. PubMed ID: 19550218
[TBL] [Abstract][Full Text] [Related]
13. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
[TBL] [Abstract][Full Text] [Related]
14. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
Sellheyer K; Nelson P
J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2, CD34 and CD10 expression in basaloid follicular hamartoma, vellus hair hamartoma and neurofollicular hamartoma demonstrate full follicular differentiation.
Ramos-Ceballos FI; Pashaei S; Kincannon JM; Morgan MB; Smoller BR
J Cutan Pathol; 2008 May; 35(5):477-83. PubMed ID: 18399809
[TBL] [Abstract][Full Text] [Related]
17. Benign ocular adnexal tumours of apocrine, eccrine or hair follicle origin.
Ozdal PC; Callejo SA; Codère F; Burnier MN
Can J Ophthalmol; 2003 Aug; 38(5):357-63. PubMed ID: 12956276
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous neuroendocrine carcinoma within a cystic trichoblastoma: a nonfortuitous association?
Battistella M; Durand L; Jouary T; Peltre B; Cribier B
Am J Dermatopathol; 2011 Jun; 33(4):383-7. PubMed ID: 21048490
[TBL] [Abstract][Full Text] [Related]
20. Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin.
Kanitakis J; Bourchany D; Faure M; Claudy A
Eur J Dermatol; 1999; 9(5):363-5. PubMed ID: 10417438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
